The Laboratory Working Party

The Laboratory Working Party (LAB WP) is chaired by Lewis While and is charged with designing studies to evaluate the variety of in-house PCR methodologies for testing whole blood, serum or plasma bronchoalveolar lavage fluid and other appropriate specimens. The LAB WP comprises 5 groups on AspergillusCandidaPneumocystis, mucorales and tissue diagnosis and meets every quarter holding at least two face-to-face meetings and relying on WEB meetings and conference calls for the remainder.

Aspergillus

Lewis White (chair)
Alexandre Alanio
Dieter Buchheidt
María José Buitrago Serna
Stephane Bretagne
Angie Caliendo
Massimo Cogliati
Martina Lengerova
Katrien Lagrou
Willem Melchers
Carlo Mengoli
Oliver Morton
Wilfried Posch
Riina Richardson
Volker Rickerts

DR. P. LEWIS WHITE, PHD

Laboratory Working Party, Panel development and distribution
NPHS Microbiology Cardiff
University Hospital of Wales
Heath Park
Cardiff. CF14 4XN
UK
Tel: +44 (0)29 2074 6581
lewis.white@nphs.wales.nhs.uk

Dr. White is the lead clinical scientist for the regional mycology laboratory, the Wales Centre for Mycobacteria and deputy head of molecular diagnostics for NPHS microbiology Cardiff.For the last 10 years his research has focused on the molecular diagnosis of invasive fungal infections, with an emphasis on Aspergillus and Candida and incorporating these tests in to a clinical setting.Additional, research has focused on antifungal susceptibility, molecular detection and identification of mycobacteria and the molecular genotyping of Mycobacterium tuberculosis.

Candida

Rebecca Gorton (Chair)
María José Buitrago Serna
Neil Clancy
Massimo Cogliati
Petr Hamal
Elisabeth Johnson
Ela Lackner
Deborah Lockhart
Willem Melchers
Carlo Mengoli
Lily Novak-Frazer
Melinda Paholcsek
Wilfried Posch
Boualem Sendid
Timoleon-Achilleas Vyzantiadis
Birgit Willinger

gorton-img_3927

DR. REBECCA GORTON

Dr Rebecca Gorton is a Lead Clinical Scientist with a BSMM diploma in Medical Mycology and a PhD in the molecular diagnosis of invasive fungal disease, both from UCL. Rebecca leads the UK Clinical Mycology Network (UK CMN) regional mycology laboratory at Health Services Laboratories (HSL), serving UCLH, Royal Free London NHS, North Middlesex and Sonic Healthcare UK, London. Rebecca is responsible for developing the mycology service through implementing integrated clinical and diagnostic testing strategies that aim to improve the detection and outcome of invasive fungal infections and improve the utility and stewardship of antifungal agents. Rebecca currently holds the post of honorary secretary for the British Society for Medical Mycology (BSMM) and is an active member of ISHAM.

Her translational research focuses on the use of MALDI-TOF MS for fungal identification, improving standardisation of biomarker assays through automation, combined P. jirovecii PCR and (1→3)-β-D-Glucan testing for the diagnosis of PCP and QuickFISH for the rapid identification of yeasts from blood cultures. More recently her research is focused on the evaluation of the T2MR Candida for the diagnosis of invasive candidiasis in the liver transplant and ICU settings.

Rebecca is the laboratory lead for the FPCRI Candida laboratory group and is also a participant in the PCP, Tissue and Aspergillus Laboratory Working parties of the FPCRI.

Pneumocystis

Alexandre Alanio (chair)
Sharon Chen
María José Buitrago Serna
Brendan Crowley
Rebecca Gorton
Malcolm Guiver
Ferry Hagen
Catriona Halliday
Katrien Lagrou
Martina Lengerova
Willem Melchers
Carlo Mengoli
Lily Novak-Frazer

alanio-768x1024

DR. ALEXANDRE ALANIO

Dr Alexandre Alanio is an M.D., Ph.D., expert in medical mycology and medical parasitology. He is currently Associate Professor in Paris VII University (Saint Louis Hospital, Paris, France), Permanent Researcher in the molecular mycology unit and Collaborator of the French National Reference Center for Mycoses and Antifungals. He received his M.D. from Paris V university medical and its Ph.D. from Paris VII University. He owns more than 50 international publications and 4 international patents. He is currently teaching at the Paris VII Medical University for medical students, at the Paris Sorbonne Paris Cité Master I Microbiology course (IMVI), and at the Medical Mycology Course of the Institut Pasteur. He is leading a group with 1 technician, 1 engineer, 1 PhD student and 1 post-doctoral research associate. He is interested in dormancy and metabolism in Fungi, in particular in Cryptococcus neoformans and in pathophysiology of invasive fungal infections. He aims at bridging medical mycology with basic research on the pathophysiology of invasive fungal infections and translating new biological tools (bench) into diagnostic test for fungal and parasitic infections (bedside).On the bedside, he is actively working on the development of new molecular diagnostic tools for pneumocystosis, histoplasmosis, mucormycosis, aspergillosis, and other mold infections. He is also interested in the molecular epidemiology of antifungal resistance in clinically relevant fungi, in particular Aspergillus fumigatusor Candida glabrata. He recently published the ECIL-5 recommendation for the diagnosis of pneumocystosis in hematology patients and is part of the ISHAM Aspergillus resistance working group. He is member of ECCMID, ISHAM and ASM and is currently associate editor for New Microbes and New infections (ESCMID Journal).

Mucorales

Laurence Millon (chair)
Alexandre Alanio
María José Buitrago Serna
Massimo Cogliati
Catriona Halliday
Ferry Hagen
Petr Hamal
Ela Lackner
Martina Lengerova
Carlo Mengoli
Katja Jaton
Lily Novak-Frazer
Wilfried Posch
Boualem Sendid
Birgit Willinger

miliion

DR. LAURENCE MILLON

Prof Laurence Millon works in the field of fungal and parasitological diseases(epidemiology, molecular and immunological diagnosis, prevention), with special focus on invasive fungal infections(Aspergillosis, Mucormycosis) and fungal allergic respiratory diseases (Hypersensitivity pneumonitis, fungal asthma). Her main expert activities include the development of molecular techniques, especially quantitative PCR assays for diagnosis and environmental assessment, and the development of recombinant antigens for serodiagnosis. She has been involved as the coordinator of multicenter studies about infectious diseases (MODIMUCOR/Prospective evaluation of a new molecular tool for early diagnosis of mucormycosis) and about allergic diseases(ELFE-EMBRASE/Microbiological Environment and Allergic Risk, cohort of 5-year-old children; SOPHIA/serodiagnosis of hypersensitivity pneumonitis using recombinant antigens).She is co-author of more than 120 indexed publications.

Tissue diagnosis

Volker Rickerts (chair)
Ralf Bialek
María José Buitrago Serna
Ferry Hagen
Catriona Halliday
Elisabeth Johnson
Martina Lengerova
Willem Melchers
Carlo Mengoli
Lily Novak-Frazer
Melinda Paholcsek
Tom Patterson
Birgit Willinger

rickerts

DR. VOLKER RICKERTS

WORK EXPERIENCE 

1998 – 2006 Training in Internal Medicine, Infectious Diseases and Medical Microbiology, University hospital Frankfurt/Main, Germany  

2007 – 2008Consultant Infectious Diseases University hospital Frankfurt: Clinical Microbiology Laboratory, Infectious diseases inpatient service, unit for highly contagious infections 

2008 – 2009Visiting Researcher Fred Hutchinson Cancer Research Cencer, Seattle, USA 

2010 – 2011Consultant Infectious Diseases University hospital Frankfurt: Clinical Microbiology Laboratory, Antimicrobial stewardship program 

2011 – present Head Mycology unit Robert Koch Institut (FG16) 

EDUCATION AND TRAINING 

1998 – 2006Training in Internal Medicine and Infectious Diseases: Board certification Internal Medicine 

2006 – 2007 Training Infectious Diseases:  Board certification Infectious Diseases  

PERSONAL SKILLS  

Medical Mycology 

Clinical Infectious diseases 

Diagnostic Microbiology